Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etimicin capsules for diarrhea-predominant irritable bowel syndrome
CTR20150640Phase 3Active
- Sponsor
- Jiangsu Jiangshan Pharmaceutical
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etimicin in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Jiangsu Jiangshan Pharmaceutical. Started Sep 2015; status: active.
02
Drugs
etimicin
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on CTR20150640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150640.